Synergistic effects of silica exposure, virus infection and genetic predisposition in systemic autoimmunity
Synergistic effects of silica exposure, virus infection and genetic predisposition in systemic autoimmunity
批准号:
10401216
负责人:
ROBERTO G BACCALA
金额:
$42.4万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-08-27 至 2022-04-30
关键词:
2019-nCoVACE2AcuteAffectAutoantibodiesAutoimmuneAutoimmune DiseasesAutoimmune ResponsesAutoimmunityCOVID-19COVID-19 pandemicCOVID-19 patientCessation of lifeChronic lung diseaseComplicationCoronavirusDevelopmentDiseaseDisease susceptibilityDoseEnvironmentEnvironmental Risk FactorEpidemiologyExposure toFibrosisFoundationsFunctional disorderFutureGeneral PopulationGeneticGenetic Predisposition to DiseaseHumanIndividualInfectionInflammationInflammatoryInflammatory ResponseInhalationLungLung diseasesLymphocytic choriomeningitis virusMineralsModelingMonitorMusParentsPathogenesisPathologyPatientsPredispositionProductionPulmonary PathologyRecording of previous eventsResistanceRespiratory FailureRoleSARS-CoV-2 infectionSilicon DioxideSilicosisSoilSymptomsSystemSystemic Lupus ErythematosusTestingTherapeutic InterventionTimeTissuesVirusVirus Diseasescoronavirus diseasecrystallinityenvironmental agentexperimental studyflulupus prone micemortalitymouse modelnovel coronavirusnovel therapeutic interventionpandemic diseasereceptorrespiratorysynergismsystemic autoimmunityvirus genetics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
COVID-19 caused by the novel coronavirus SARS-Cov-2 first emerged in December 2019 and was officially
declared a pandemic by WHO in March 2020. During this time, COVID-19 has caused millions of cases and
deaths across the world. While most cases are asymptomatic or present with mild respiratory and flu-like
symptoms, a significant fraction of COVID-19 patients develop severe pulmonary complications,
overproduction of inflammatory factors and other manifestations, leading in critical cases to multiorgan
dysfunction, respiratory failure and death. Strikingly, recent evidence indicates that, besides the typical
severe lung pathology, SARS-Cov-2 infection also promotes autoantibody production and other autoimmune
manifestations in some patients. However, why other patients seem protected and the mechanisms for
COVID-19-associated autoimmunity remain unknown. We hypothesize that autoimmunity development in
SARS-Cov-2-infected patients depends on genetic predisposition but also on the history of the individual’s
exposure to environmental triggers, including crystalline silica, an abundant mineral often associated with
autoimmunity. To test this possibility, in this supplemental application we propose experiments with mice
expressing human ACE2, the receptor for SARS-Cov-2. These mice will be infected with SARS-Cov-2 at
doses that induce low-level COVID-related pathology but no mortality, allowing long-term monitoring for
autoimmunity. We will test the effect of the time of SARS-Cov-2 infection and airway exposure to crystalline
silica on autoimmune manifestations in hACE2-expressing non-autoimmune and lupus-prone mouse models.
In addition, we will examine how the dose of silica affects induction of autoimmunity in SARS-Cov-2-infected
mice. The results will provide proof of concept that exposure to environmental agents may exacerbate
COVID-19-associated inflammatory and autoimmune responses, creating the foundation for future studies to
assess the effect of other environmental triggers, mechanisms of disease pathogenesis, and potential
therapeutic interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Differential role of TASL and SLC15A4 in TLR responses to nucleic acids and lupus development
-
批准号:10583337
-
项目类别:
-
资助金额:$28.8万
-
财政年份:2022
-
负责人:ROBERTO G BACCALA
-
依托单位:
Synergistic effects of silica exposure, virus infection and genetic predisposition in systemic autoimmunity
-
批准号:10379171
-
项目类别:
-
资助金额:$42.23万
-
财政年份:2021
-
负责人:ROBERTO G BACCALA
-
依托单位:
Synergistic effects of silica exposure, virus infection and genetic predisposition in systemic autoimmunity
-
批准号:10615669
-
项目类别:
-
资助金额:$41.57万
-
财政年份:2021
-
负责人:ROBERTO G BACCALA
-
依托单位:
Synergistic effects of silica exposure, virus infection and genetic predisposition in systemic autoimmunity
-
批准号:10372295
-
项目类别:
-
资助金额:$43.2万
-
财政年份:2021
-
负责人:ROBERTO G BACCALA
-
依托单位:
Synergistic effects of silica exposure, virus infection and genetic predisposition in systemic autoimmunity
-
批准号:10053262
-
项目类别:
-
资助金额:$39.94万
-
财政年份:2020
-
负责人:ROBERTO G BACCALA
-
依托单位:
Genetic Dissection of arenavirus-induced lethality
-
批准号:9088332
-
项目类别:
-
资助金额:$24.06万
-
财政年份:2015
-
负责人:ROBERTO G BACCALA
-
依托单位:
Cysteine Protease Network in Tumor Progression and Therapy
-
批准号:8014894
-
项目类别:
-
资助金额:$34.92万
-
财政年份:2007
-
负责人:ROBERTO G BACCALA
-
依托单位:
Anti-Tumor Autoimmunity by lymphopenia T cell Expansion
-
批准号:7369853
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2005
-
负责人:ROBERTO G BACCALA
-
依托单位:
Anti-Tumor Autoimmunity by lymphopenia T cell Expansion
-
批准号:7026954
-
项目类别:
-
资助金额:$32.27万
-
财政年份:2005
-
负责人:ROBERTO G BACCALA
-
依托单位:
Anti-Tumor Autoimmunity by lymphopenia T cell Expansion
-
批准号:6921788
-
项目类别:
-
资助金额:$33.04万
-
财政年份:2005
-
负责人:ROBERTO G BACCALA
-
依托单位:
Anti-Tumor Autoimmunity by lymphopenia T cell Expansion
-
批准号:7211341
-
项目类别:
-
资助金额:$31.33万
-
财政年份:2005
-
负责人:ROBERTO G BACCALA
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
-
批准号:JCZRLH202600625
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
-
批准号:2026JJ50619
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:翁春艳
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介
导“肠-胰岛 ”轴血糖调控功能的降糖机制研
究
-
批准号:Y24H280055
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:颜美秋
-
依托单位:
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
-
批准号:82330111
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:刘刚
-
依托单位:
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
-
批准号:82373169
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:顾良友
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
-
批准号:32300137
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈静
-
依托单位:
基于外泌体miRNAs介导细胞通讯的大豆ACE2激活肽调控血管稳态机制研究
-
批准号:32302080
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:宋田源
-
依托单位:
基于AT2/ACE2/Ang(1-7)/MAS轴调控心脏-血管-血液系统性重构演变规律研究心衰气虚血瘀证及其益气通脉活血化瘀治法生物学基础
-
批准号:82305216
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:姚骏凯
-
依托单位:
感毒清经ACE2/Ang(1-7)/MasR信号通路抑制PM2.5诱导慢性气道炎症的机制:聚焦肺泡巨噬细胞极化与“胞葬”的表型串扰
-
批准号:82305171
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:吴永灿
-
依托单位: